成大生物：已累计斥资1078.92万元回购0.092%股份

Core Viewpoint - The company plans to repurchase shares using excess funds raised, with a focus on employee stock ownership plans or equity incentives, indicating a commitment to enhancing shareholder value and employee engagement [1] Summary by Sections Share Repurchase Plan - The company intends to use between 10 million to 20 million yuan of excess funds for share repurchase through centralized bidding [1] - The maximum repurchase price is set at 38 yuan per share, with the repurchase period extending until June 18, 2026 [1] Current Repurchase Status - As of October 31, 2025, the company has repurchased a total of 384,899 shares, which represents 0.092% of the total share capital [1] - The total amount paid for the repurchased shares is 10.7892 million yuan, with individual repurchase prices ranging from 27.20 yuan to 29.61 yuan per share [1] - No repurchase activity was conducted in October [1]